TrialDiabetes, obesity & metabolism2018

Single and multiple dose evaluation of a novel MetAP2 inhibitor: Results of a randomized, double-blind, placebo-controlled clinical trial.

Jaret Malloy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.